Login with your work email address to view charts. No credit card required.
| Art Unit: | 1674 — Drug, bio-affecting and body treating compositions |
|---|---|
| Group: | 1670 — Virology, Viral Immunology, And Viral Pathogens, Neurology, Receptors, Cytokines & Recombinant Hormones and Immunoassays and related devices |
| Classes: |
514 — Drug, bio-affecting and body treating compositions 424 — Drug, bio-affecting and body treating compositions 435 — Chemistry: molecular biology and microbiology 530 — Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof 604 — Surgery 536 — Organic compounds -- part of the class 532-570 series 436 — Chemistry: analytical and immunological testing 506 — Combinatorial chemistry technology: method, library, apparatus |
| Phone: | (571) 272-2922 |
| Email: | gyan.chandra@uspto.gov |
| Location: | VA 22314 |
| Title: | Pat Examnr (Biolgy) |
| Service: | 22 years |
| Grade: | GS-14 |
| 3-Year Grant rate: | 69% over 366 cases |
|---|---|
| Difficulty: | Harder |
| Difficulty Percentile: | 63rd
|
With Examiner Chandra, you have a 69% chance of getting an issued patent by 3 years after the first office action. Examiner Chandra is a harder examiner and in the 63rd percentile across all examiners (with 100th percentile most difficult).
Below is the grant rate timeline for Examiner Chandra, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Examiner Chandra's grant rate is higher than that of Art Unit 1674 and lower than that of the USPTO.
| Average Office Actions Per Grant | |
|---|---|
| Examiner Chandra | 1.5 |
| Art Unit 1674 | 1.3 |
Examiner Chandra has granted 212 of 317 cases without any applicant-requested interviews for a grant rate of 67%.
Examiner Chandra has granted 41 of 49 cases with at least one applicant-requested interview for a grant rate of 84%.
With Examiner Chandra, conducting an interview increases your chance of getting a patent granted by 25%.
| Number | Title | OA Rejections | Status | IFW |
|---|---|---|---|---|
| 18300354 | Methods Of Reducing Neuroinflammation | Rejection information available with a Premium Stats subscription. See our pricing. | Patented | View |
| 18345775 | Therapeutic Derivatives Of Interleukin-22 | Abandoned | View | |
| 17930144 | Use Of Gp73 Inhibitor In Preparation Of Medicine For Treating Diabetes | Abandoned | View | |
| 17615595 | Hla Tumor Antigen Peptides Of Class I And Ii For Treating Mammary/breast Carcinomas | Patented | View | |
| 18477276 | Compositions And Methods For Peptide Production | Patented | View | |
| 17758089 | Insulin Derivative | Patented | View | |
| 17781530 | Cyclooxygenase-2 Inhibition For The Treatment Of Saa-High Asthma | Abandoned | View | |
| 18384511 | Prodrugs And Uses Thereof | Abandoned | View | |
| 18979068 | Methods For Treating Alzheimer's Disease Using Semaglutide | Patented | View | |
| 18929081 | Compositions And Methods For Treating Metabolic Disorders | Patented | View | |
| 19041480 | Pharmaceutical Composition For Treating And/or Preventing Renal Cystic Ciliopathy | Patented | View | |
| 18357666 | Treatment Of Exercise-Induced Hypoglycemia In Type 1 And Insulin Using Type 2 Diabetes | Patented | View | |
| 18572577 | Semaglutide Depot Systems And Use Thereof | Patented | View | |
| 17848974 | Compositions And Methods For Treating Obesity And Hyperphagia | Patented | View | |
| 18573779 | Methods Of Using And Compositions Including An Incretin Analog | Patented | View | |
| 17461748 | Photoresponsive Liposome, Complex, Measurement System, And Measurement Method | Patented | View | |
| 18634496 | Fusion Proteins For The Treatment Of Cardiometabolic Diseases | Patented | View | |
| 18304074 | Novel Method For Preparing Long-Acting Drug Conjugate Through Preparation Of Intermediate | Patented | View | |
| 18122991 | Reconstitutable Teverelix-Tfa Composition | Patented | View | |
| 18341404 | Method Of Reducing Glucose Intolerance Or Insulin Resistance In A Patient In Need Thereof | Patented | View | |
| 18907424 | Vasopressin Premix Systems And Uses Thereof | Patented | View | |
| 18345832 | Therapeutic Derivatives Of Interleukin-22 | Patented | View | |
| 18889097 | Insulin Derivative | Abandoned | View | |
| 17320118 | Engineered Cd25 Polypeptides And Uses Thereof | Patented | View | |
| 17997363 | Treating Cancer With A Conjugate Comprising An Il-2 Moiety | Patented | View | |
| 18449876 | Bcma Antibodies And Use Of Same To Treat Cancer And Immunological Disorders | Abandoned | View | |
| 18199817 | Gata3 Inhibitors For Treating Insulin Resistance | Patented | View | |
| 18967259 | Compositions And Methods For Treating Diabetes | Patented | View | |
| 17895638 | Insulin-Transferrin Fusion Protein And Its Prodrug, Proinsulin-Transferrin, For Overcoming Insulin Resistance | Patented | View | |
| 17549770 | Pharmaceutical Composition Comprising Frataxin Fusion Protein And Methods Of Use Thereof | Patented | View | |
| 18331197 | Liquid Pharmaceutical Compositions Of Polypeptide Conjugates And Methods Of Uses Thereof | Patented | View | |
| 18087273 | Short Chain Ceramide-Based Lipids And Uses Thereof | Patented | View | |
| 18087345 | Administration Of An Anti-Activin-A Compound To A Subject | Patented | View | |
| 18720291 | Il-4 Derived Peptides For Use In The Treatment Of Obesity | Patented | View | |
| 18319010 | Methods Comprising Continuous Administration Of A Glp-1 Receptor Agonist And Co-Administration Of A Drug | Abandoned | View | |
| 18230086 | Therapeutic Agent Preparations For Delivery Into A Lumen Of The Intestinal Tract Using A Swallowable Drug Delivery Device | Abandoned | View | |
| 17836644 | Anti-Sortilin Antibodies And Methods Of Use Thereof | Patented | View | |
| 17289898 | Combination Therapy Method Of Treating Myeloproliferative Neoplasms With A Diphtheria Toxin-Human Interleukin-3 Conjugate In Combination With Other Agents | Patented | View | |
| 18318492 | Methods Of Treating Neutorpenia Using G-Csf Protein Complex | Patented | View | |
| 18196813 | Preparation Comprising Exanatide For Delivery Into A Lumen Of The Intestinal Tract | Abandoned | View | |
| 18181852 | Novel Methods Of Treating Neutorpenia Using G-Csf Protein Complex | Patented | View | |
| 17254004 | Novel Interleukin-15 (Il-15) Fusion Proteins And Uses Thereof | Patented | View | |
| 17588377 | Methods And Compositions For Oral Administration | Patented | View | |
| 17562435 | Rapid-Acting Insulin Analogues Of Enhanced Stability | Patented | View | |
| 17118915 | Method To Prepare Therapeutically Active Aldesleukin Highly Stable In Liquid Pharmaceutical Compositions | Patented | View | |
| 18807825 | April And Baff Inhibitory Immunomodulatory Proteins And Methods Of Use Thereof | Patented | View | |
| 18077742 | Use Of Ultrarapid Acting Insulin | Patented | View | |
| 17747723 | Pharmaceutical Composition Comprising A Glp-1-Agonist And Methionine | Patented | View | |
| 17836707 | Anti-Sortilin Antibodies And Methods Of Use Thereof | Patented | View | |
| 17237650 | Anti-Tnf Antibodies, Compositions, And Methods For The Treatment Of Active Ankylosing Spondylitis | Patented | View |
Subscribe to Premium Examiner Statistics for unlimited access for your law firm.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.